Literature DB >> 15990405

Peptide-based strategy for siRNA delivery into mammalian cells.

Federica Simeoni1, May C Morris, Frederic Heitz, Gilles Divita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15990405     DOI： 10.1385/1-59259-935-4:251

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  8 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

2.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

Authors:  Laurence Crombez; Gudrun Aldrian-Herrada; Karidia Konate; Quan N Nguyen; Gary K McMaster; Robert Brasseur; Frederic Heitz; Gilles Divita
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

Review 3.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

4.  Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing.

Authors:  Pim-on Rujitanaroj; Brian Jao; Junghoon Yang; Feng Wang; James M Anderson; Jun Wang; Sing Yian Chew
Journal:  Acta Biomater       Date:  2012-10-02       Impact factor: 8.947

5.  Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.

Authors:  Jiehua Zhou; Haitang Li; Shirley Li; John Zaia; John J Rossi
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

6.  Aptamer mediated siRNA delivery.

Authors:  Ted C Chu; Karen Y Twu; Andrew D Ellington; Matthew Levy
Journal:  Nucleic Acids Res       Date:  2006-06-01       Impact factor: 16.971

Review 7.  Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.

Authors:  Ghanbar Mahmoodi Chalbatani; Hassan Dana; Elahe Gharagouzloo; Santiago Grijalvo; Ramon Eritja; Craig D Logsdon; Fereidoon Memari; Seyed Rouhollah Miri; Mahdi Rezvani Rad; Vahid Marmari
Journal:  Int J Nanomedicine       Date:  2019-05-02

Review 8.  Progress towards in vivo use of siRNAs.

Authors:  Mark A Behlke
Journal:  Mol Ther       Date:  2006-02-14       Impact factor: 11.454
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.